Second study reveals prevalence of 8.7 percent for elevated BP, 5.4 percent for hypertension among youth aged 8 to 19 years
Empagliflozin Confers Kidney-Protective Benefits After Acute MI
Reduced risk seen for total hospitalizations for heart failure, total adverse events of heart failure or all-cause mortality